Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate

Medical treatment and chemotherapy are seldom successful in achieving objective tumour reduction in patients with metastatic neuroendocrine tumours. Treatment with the radiolabelled somatostatin analogue [(90)Y-DOTA(0),Tyr(3)]octreotide may result in partial remissions in 10–25% of patients. The new...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., Erion, J. L., Krenning, E. P.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2003
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1998890/
https://www.ncbi.nlm.nih.gov/pubmed/12634971
http://dx.doi.org/10.1007/s00259-002-1050-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1998890/
https://www.ncbi.nlm.nih.gov/pubmed/12634971
http://dx.doi.org/10.1007/s00259-002-1050-8

Ejemplares similares